FundingWatcher
Home / Startups / Top health care startups / Health care startups in Shanghai, China

Health care startups in Shanghai, China

Updated 16 Nov 2026

Reset
Health care startups in Shanghai, China
One-time CSV
  • 447 funded companies, 281 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care~shanghai-shanghai.csv447 rows × 18 columns
CompanyCityLast roundAmountDate
EnjosimShanghaiSeries B$30.1M2026-11-02
Degron TherapeuticsShanghaiSeries A$40.0M2026-05-14
MindRank AIShanghaiSeries B$52.0M2026-07-08
Bluesail SurgicalShanghaiSeries B$104.5M2026-09-23
Full-Life TechnologiesShanghaiSeries D$109.0M2026-05-18
Nutshell TherapeuticsShanghaiSeries C$40.0M2026-09-15
Phrontline BiopharmaShanghaiSeed$60.0M2025-11-21
BivisionShanghaiSeries B$58.8M2026-05-18

8 rows of the CSV in 5 of its 18 columns.

447
Startups
$12.1B
Total raised
70
Funded in the last 12 months
$1.8B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

15 of 447
15 rows
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
Enjosim Enjosim researches, manufactures, and sells self-delivery systems for biomacromolecule pharmaceuticals. Biotech Series B $30.1M 2026-11-02 $30.1M Luminous Ventures (former Lightspeed China Partners), Jiayuan Capital 51 to 100 2021
Bluesail Surgical Bluesail Surgical develops surgical instruments for cardiovascular treatments. Biotech Series B $104.5M 2026-09-23 $245.4M Huagai Capital, Linkong Private Equity Fund Management, Linqu County High-Tech Industrial Investment 101 to 250 2020
Nutshell Therapeutics Nutshell Therapeutics discovers small-molecule drugs using insights from protein dynamics. Artificial intelligence Series C $40.0M 2026-09-15 $75.2M Matrix Partners China, Source Code Capital, Northern Light Venture Capital +1 51 to 100 2013
MindRank AI MindRank AI develops artificial intelligence platforms to discover and develop small molecule drugs. Artificial intelligence Series B $52.0M 2026-07-08 $101.0M Green Pine Capital Partners, Huagai Capital, Sherpa Healthcare Partners +1 11 to 50 2020
Full-Life Technologies Full-Life Technologies develops, produces, and commercializes medicines for cancer therapy. Biotech Series D $109.0M 2026-05-18 $337.3M Sky9 Capital, Chengwei Capital, Prosperity7 Ventures +1 51 to 100 2021
Bivision Bivision researches and develops targeted radiopharmaceuticals for therapy. Biotech Series B $58.8M 2026-05-18 $100.9M Gaorong Capital, Kaitai Capital, Lichen Capital 11 to 50 2021
Degron Therapeutics Degron Therapeutics discovers molecular glue degraders for cancer treatment. Biotech Series A $40.0M 2026-05-14 $94.0M Baidu Ventures, BioVenture, New Alliance Capital +2 101 to 250 2021
Novamab Novamab researches and develops new nanobodies. Biotech Series B $43.9M 2026-04-24 $97.8M Qiming Venture Partners, Taiyu Investment, Fuho Capital +1 51 to 100 2017
CORXEL Pharmaceuticals CORXEL Pharmaceuticals develops medicines for underserved patients. Biotech Series D $287.0M 2026-01-22 $451.8M Leaps by Bayer, RTW Investments 51 to 100 2019
Alioth Alioth develops and applies technical products for pharmaceutical process technology. Biotech Series B $14.4M 2026-01-15 $54.7M Matrix Partners China, Legend Capital 51 to 100 2021
Allink Biotherapeutics Allink Biotherapeutics develops multi-specific antibodies for treating cancer and immune disorders. Biotech Series A $47.0M 2025-12-16 $89.0M Legend Capital, Gaorong Capital, BioVenture +2 11 to 50 2023
Phrontline Biopharma Phrontline Biopharma develops antibody-drug conjugate products to treat cancer. Biotech Seed $60.0M 2025-11-21 $73.8M Decheng Capital, Med-Fine Capital 11 to 50 2022
Brise Pharma Brise Pharma provides scientific research and technical services in the pharmaceutical field. Biotech Series A $28.1M 2025-11-11 $228.3M Qiming Venture Partners, Sherpa Healthcare Partners, BioTrack Capital +1 11 to 50 2021
GRIT Biotechnology GRIT Biotechnology develops tumor infiltrating lymphocyte immunotherapy for solid tumors. Biotech Series C $84.0M 2025-10-14 $153.5M Matrix Partners China, Hillhouse Investment, CICC +2 51 to 100 2019
Meiyou Technology Meiyou Technology develops DNA synthesizers using enzymatic technology for long-fragment DNA synthesis and splicing. Biotech Angel $1.4M 2024-06-28 MiraclePlus, Linear Capital, Danen Capital 11 to 50 2023

Table 1. Health care startups in Shanghai, China: the 15 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 447.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 CORXEL Pharmaceuticals CORXEL Pharmaceuticals develops medicines for underserved patients. Biotech Series D $287.0M 2026-01-22 $451.8M Leaps by Bayer, RTW Investments 51 to 100 2019
2 Full-Life Technologies Full-Life Technologies develops, produces, and commercializes medicines for cancer therapy. Biotech Series D $109.0M 2026-05-18 $337.3M Sky9 Capital, Chengwei Capital, Prosperity7 Ventures +1 51 to 100 2021
3 Bluesail Surgical Bluesail Surgical develops surgical instruments for cardiovascular treatments. Biotech Series B $104.5M 2026-09-23 $245.4M Huagai Capital, Linkong Private Equity Fund Management, Linqu County High-Tech Industrial Investment 101 to 250 2020
4 Phrontline Biopharma Phrontline Biopharma develops antibody-drug conjugate products to treat cancer. Biotech Seed $60.0M 2025-11-21 $73.8M Decheng Capital, Med-Fine Capital 11 to 50 2022
5 Bivision Bivision researches and develops targeted radiopharmaceuticals for therapy. Biotech Series B $58.8M 2026-05-18 $100.9M Gaorong Capital, Kaitai Capital, Lichen Capital 11 to 50 2021
6 MindRank AI MindRank AI develops artificial intelligence platforms to discover and develop small molecule drugs. Artificial intelligence Series B $52.0M 2026-07-08 $101.0M Green Pine Capital Partners, Huagai Capital, Sherpa Healthcare Partners +1 11 to 50 2020
7 Allink Biotherapeutics Allink Biotherapeutics develops multi-specific antibodies for treating cancer and immune disorders. Biotech Series A $47.0M 2025-12-16 $89.0M Legend Capital, Gaorong Capital, BioVenture +2 11 to 50 2023
8 Novamab Novamab researches and develops new nanobodies. Biotech Series B $43.9M 2026-04-24 $97.8M Qiming Venture Partners, Taiyu Investment, Fuho Capital +1 51 to 100 2017
9 Nutshell Therapeutics Nutshell Therapeutics discovers small-molecule drugs using insights from protein dynamics. Artificial intelligence Series C $40.0M 2026-09-15 $75.2M Matrix Partners China, Source Code Capital, Northern Light Venture Capital +1 51 to 100 2013
10 Degron Therapeutics Degron Therapeutics discovers molecular glue degraders for cancer treatment. Biotech Series A $40.0M 2026-05-14 $94.0M Baidu Ventures, BioVenture, New Alliance Capital +2 101 to 250 2021

Table 2. Health care startups in Shanghai, China: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Sherpa Healthcare Partners Venture capital firm Beijing, China 7 2% 1 MindRank AI
2 Matrix Partners China Venture capital firm Beijing, China 6 1% 2 Nutshell Therapeutics, Alioth
3 Qiming Venture Partners Venture capital firm Shanghai, China 5 1% 1 Novamab
4 Taiyu Investment Venture capital firm Beijing, China 5 1% 1 Novamab
5 BioVenture Venture capital firm Suzhou, China 4 1% 2 Degron Therapeutics, Allink Biotherapeutics
6 Northern Light Venture Capital Venture capital firm Beijing, China 4 1% 1 Nutshell Therapeutics
7 Baidu Ventures Venture capital firm Beijing, China 3 1% 2 Nutshell Therapeutics, Degron Therapeutics
8 Med-Fine Capital Venture capital firm Shanghai, China 3 1% 2 Degron Therapeutics, Phrontline Biopharma
9 Gaorong Capital Venture capital firm Wangjing, China 3 1% 2 Bivision, Allink Biotherapeutics
10 Legend Capital Venture capital firm Beijing, China 3 1% 2 Alioth, Allink Biotherapeutics
11 CICC Investment bank Beijing, China 3 1% 1 Etern
12 BioTrack Capital Venture capital firm Shanghai, China 3 1%
13 Lilly Asia Ventures Venture capital firm Shanghai, China 3 1%
14 SOSV Venture capital firm Princeton, United States 3 1%
15 Luminous Ventures (former Lightspeed China Partners) Venture capital firm Shanghai, China 2 0% 1 Enjosim

Table 3. Health care startups in Shanghai, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 194 43% $7.3B
Software 50 11% $561.6M
Hardware 17 4% $53.5M
Artificial intelligence 13 3% $378.7M
Commerce 12 3% $30.6M
Fintech 11 2% $1.2B
Education 5 1% $40.7M
Cybersecurity 2 0%
Energy 2 0%

Table 4. Health care startups in Shanghai, China by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 1 0% $120K
Seed 111 25% $1.5M
Series A 149 33% $13.8M
Series B 106 24% $25.0M
Series C 50 11% $42.2M
Series D+ 30 7% $86.2M

Table 5. Health care startups in Shanghai, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 6 9% $99.7M
October 2026 1 1% $105.0M
September 2026 5 7% $266.0M
August 2026 3 4% $1.5M
July 2026 8 11% $297.3M
June 2026 1 1%
May 2026 9 13% $288.8M
April 2026 5 7% $159.9M
March 2026 6 9% $35.9M
February 2026 3 4% $23.0M
January 2026 10 14% $365.6M
December 2025 11 16% $140.2M
November 2025 2 3% $60.0M

Table 6. Health care startups in Shanghai, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 57 13% $1.6B
2025 66 15% $1.0B
2024 31 7% $263.5M
2023 36 8% $344.2M
2022 35 8% $764.5M
2021 60 13% $2.1B

Table 7. Health care startups in Shanghai, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 26 6%
2020 to 2022 98 22%
2015 to 2019 161 37%
2010 to 2014 110 25%
Before 2010 46 10%

Table 8. Health care startups in Shanghai, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 48 13%
11 to 50 129 35%
51 to 100 69 19%
101 to 250 53 14%
251 to 500 31 8%
501 to 1,000 21 6%
1,001 to 5,000 11 3%
5,001 to 10,000 3 1%
10,001 or more 1 0%

Table 9. Health care startups in Shanghai, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in Shanghai, China are on the list?
447, in the file dated 16 November 2026. 70 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 447 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups in Shanghai, China: 447 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care startups in Shanghai, China by funding stage

Other sectors in Shanghai

Health care startups elsewhere

Cite: FundingWatcher, 447 funded health care companies in Shanghai, China, 16 November 2026. https://fundingwatcher.com/startups/health-care/shanghai-shanghai/